Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461291 · ClinicalTrials.gov registry record · NA
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
A NA study, sponsored by Glaukos Corporation.
- Completed
- Registry status
- NA
- Development phase
- 505
- Enrollment target
NCT01461291 is a NA study that has completed, run by Glaukos Corporation. The registered enrollment target is 505 participants.
The verdict
NCT01461291, a NA study, has completed, sponsored by Glaukos Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 505 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery vs. cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.
Interventions
- PROCEDURE Cataract surgery
- DEVICE iStent inject
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2012-01-16 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01461291
The ClinicalTrials.gov registry entry for NCT01461291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 505 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cataract surgery is the first listed.
NCT01461291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01461291 about?
NCT01461291 is a clinical study titled "Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery". Evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery vs. cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.
What is the current status of trial NCT01461291?
This trial is currently completed. It is a NA study. The enrollment target is 505 participants. The study started on 2012-01-16. Estimated completion is 2018-10.
What interventions are being tested in trial NCT01461291?
The interventions under investigation include: Cataract surgery (PROCEDURE), iStent inject (DEVICE).
Who is sponsoring clinical trial NCT01461291?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.